The Bureau International des Expositions (BIE) announces the official list of candidates for Specialised Expo 2022/23: Poland (Łódź), United States (Minneapolis), Brazil (Rio de Janeiro) and Argentina (Buenos Aires)
The Bureau International des Expositions (BIE) has closed the candidature period for Specialised Expo 2022/23. Four countries have submitted competing bids to organise Specialised Expo 2022/23: the Republic of Poland, the United States of America, the Federative Republic of Brazil and the Republic of Argentina.
The 169 Member States of the BIE will elect the host country of Specialised Expo 2022/23 at the 162nd General Assembly in November 2017.
Poland ’s bid is for a Specialised Expo in the city of Łódź between 15 June and 15 September 2022 under the theme “City Re:Invented.”
The United States ’ bid is for a Specialised Expo in Minneapolis between 15 May and 15 August 2023 under the theme “Wellness and Well Being for All: Healthy People, Healthy Planet.” The United States is not a Member State of the BIE.*
Brazil ’s bid is for a Specialised Expo in Rio de Janeiro between 4 March and 27 May 2022 under the theme “Metropolitan Cities and Sustainability: Cross Border Potentials.”
Argentina ’s bid is for a Specialised Expo in Buenos Aires between 15 January and 15 April 2023 under the theme “Science, Innovation, Art and Creativity for the Human Development.”
The Secretary General of the BIE, Vicente G. Loscertales, stated that “these four candidatures demonstrate a high level of interest for this type of Expo.” The project examination phase for Specialised Expo 2022/23 will take place over the next few months. Each candidate will submit a bid dossier, to be followed by a BIE Enquiry Mission. The projects will then be presented to the General Assembly of the BIE on 14 June 2017. The election of the host country by the 169 Member States of the BIE will take place at the subsequent General Assembly in November 2017.
Specialised Expos, known officially as International Recognised Exhibitions, can be organised in the interval between two World Expos. They can last up to three months and are designed to respond to a precise challenge facing humanity. The most recent Specialised Expo was held in the city of Yeosu in the Republic of Korea in 2012, which attracted over 8 million visitors under the theme “The Living Ocean and Coast”. The next Specialised Expo is to take place in Astana, the capital of Kazakhstan, between 10 June and 10 September 2017 under the theme “Future Energy”.
* In accordance with BIE regulations, Member States must be given priority over non-Member States.
The Bureau International des Expositions (BIE) is the intergovernmental organisation embodying the commitment of its 169 member States to lead, promote and foster International Exhibitions for the benefit of the citizens of the international community.
The BIE oversees four types of International Exhibitions: World Expos (International Registered Exhibitions), Specialised Expos (International Recognised Exhibitions), Horticultural Expos and the Triennale di Milano.
International Exhibitions are global events dedicated to finding solutions to specific challenges facing humanity by offering a journey inside the Expo theme through engaging and immersive activities.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SEOUL-SEMICONDUCTOR23.3.2018 19:30 | pressemeddelelse
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine
ELLIOTT-MANAGEMENT-CORP23.3.2018 17:07 | pressemeddelelse
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:54 | pressemeddelelse
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:52 | pressemeddelelse
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets
JANSSEN23.3.2018 13:48 | pressemeddelelse
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)
AITHEON23.3.2018 13:02 | pressemeddelelse
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum